ARTICLE | Clinical News
MS-325 regulatory update
February 23, 2004 8:00 AM UTC
FDA accepted for filing the partners' NDA for MS-325 injectable gadolinium magnetic resonance angiography ( MRA) contrast agent for vascular imaging. The NDA has a mid-October PDUFA date. ...